Every 8-K that EARTH SCIENCE TECH INC (ETST) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow ETST and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ETST filings page.
Earth Science Tech, Inc. (ETST) reported the results of its first annual shareholder meeting held virtually on August 31, 2026. Shareholders re-elected all seven director nominees and ratified Semple, Marchal & Cooper, LLP as independent registered public accounting firm for the fiscal year ending March 31, 2027.
Holders approved a non-binding proposal authorizing the Board to pursue a reverse stock split, valid for 12 months and to be used strictly if deemed necessary to meet minimum bid price requirements for an uplisting to a national securities exchange. Shareholders also supported a non-binding advisory proposal authorizing the Board’s independent Special Committee to negotiate the retirement of the Series B Preferred Stock, which the company states would eliminate its dual-class, super-voting control structure.
In advisory votes on compensation, shareholders approved the company’s cash-only, non-dilutive executive compensation structure and selected a three-year frequency for future Say-on-Pay votes. A press release summarizing these results was furnished, and an audio replay of the meeting, including Q&A and management commentary, was made available.
Earth Science Tech, Inc. (ETST) reported that on August 17, 2026 it completed the acquisition of Zoolzy LLC, a Florida-based wholesale distributor of active pharmaceutical ingredients (APIs) and FDA-approved prescription products. The purchase terms were not disclosed because the amount was deemed immaterial.
Zoolzy operates from a 3,684-square-foot facility in Doral, Florida and is expected to enhance ETST’s vertically integrated healthcare platform by internalizing API procurement, broadening access to novel ingredients, and enabling a strategic push into veterinary therapeutics. The seller was Mario G. Tabraue, ETST’s COO and director; independent board members reviewed and approved this related-party transaction to confirm that its terms were fair and comparable to those from unaffiliated third parties.
Earth Science Tech, Inc. reports that on August 11, 2026 it entered into an agreement to acquire Meduvo LLC, a compounding pharmacy based in La Verne, California. The consideration was not disclosed, with the company stating the amount was immaterial.
Meduvo currently operates from a 2,000-square-foot facility and compounds and dispenses non-sterile medications. The acquisition creates a West Coast operational hub and expands Earth Science Tech’s compounding pharmacy network to 34 U.S. jurisdictions, with regulatory approvals for remaining states actively pending as the company seeks nationwide coverage.
The seller is Mario G. Tabraue, the company’s Chief Operations Officer and board member, making this a related party transaction. Independent directors reviewed and approved the deal, stating the terms were fair, reasonable, and comparable to those available from unaffiliated third parties. Management plans facility upgrades to meet sterility requirements and targets full regulatory certification for sterile compounding by the end of 2028.
Earth Science Tech, Inc. reported fiscal first quarter 2027 results for the period ended June 30, 2026, showing modest revenue growth and much stronger profitability. Revenue was $9.0 million compared to $8.8 million, with gross profit of $6.3 million compared to $6.1 million.
Net income rose 57% to $715,697 from $456,714, and diluted EPS more than tripled to $0.003 from $0.001. Net cash provided by operating activities increased 108.4% to $707,131 from $339,376, and total assets reached $10.4 million on June 30, 2026, up from $7.8 million a year earlier. All key operating subsidiaries were profitable. The company repurchased and retired over 3.7 million shares of common stock during the quarter, compared to 505,000 in the prior-year period, without adding debt. An Annual Meeting on August 31, 2026 will address proposals including cancellation of Series B Preferred Stock and discussion of a potential exchange uplisting.
Earth Science Tech, Inc. reported full-year results for the fiscal year ended March 31, 2026, showing higher revenue and earnings while reducing debt. Revenue increased to $35,695,614 from $33,117,624, and net income rose to $3,600,937 from $3,253,635, with earnings per share improving to $0.012.
The company ended the year with total assets of $8,969,337 and total liabilities of $1,928,573, resulting in total equity of $7,040,764. Management highlighted positive operating cash flow, a stronger balance sheet without adding new debt, and share repurchases and retirements of more than 7.1 million common shares in fiscal 2026, plus over 3.1 million additional shares bought in fiscal Q1 2027.
Earth Science Tech, Inc. provided a shareholder update highlighting major milestones for the fiscal year ended March 31, 2026. The company reports repurchasing over 6.9 million shares of common stock since fiscal Q1 2026 and states it has been cash flow positive across its operating platform while pursuing debt-free growth.
The Health/Wellness segment is described as the core operating engine expected to generate most revenue, with Peaks Curative surpassing $2 million in revenue in the first week of fiscal Q4 2026. Management also notes three additional properties under development awaiting final permits and says 3,150,392 shares of common stock have been retired quarter-to-date, positioning the company, in its view, in real financial strength entering the new fiscal year.
Earth Science Tech, Inc. reported that its Board of Directors amended Article I, Section 4 of its Bylaws, effective April 16, 2026. The change permits delivery of shareholder meeting notices by electronic transmission, including email, to modernize corporate governance, improve administrative efficiency, and reduce printing and mailing costs. The amended bylaw language is set out in a Board Resolution filed as Exhibit 3.1 to this report.
Earth Science Tech, Inc. reports the launch of MyOnlineConsultation.com through its MOCTeledoc, LLC division, completing what it describes as a fully vertically integrated telehealth and pharmacy ecosystem. MOCTeledoc is introduced as a doctor network that provides both technology and clinical staffing to digital health companies.
The company states that MOCTeledoc was cash-flow-positive during its beta phase and is expected to be immediately accretive to earnings as it is rolled out nationwide. Management highlights that offering the custom telehealth platform and prescriber network as a turnkey service creates a new revenue stream and a funnel to Earth Science Tech’s in-house compounding pharmacies.
The filing also reiterates that Earth Science Tech is a diversified health and wellness holding company operating compounding pharmacies, telemedicine platforms, targeted healthcare facilities, a real estate and asset management arm, a consumer products brand, and a non-profit foundation supporting patient prescription costs.
Earth Science Tech, Inc. reported that on March 11, 2026 it mutually agreed to renew the employment agreements of Chief Financial Officer Ernesto L. Flores and Chief Technology Officer Christopher A. Rose for an additional one-year term.
The original agreements were entered into on March 11, 2025, and all other material terms and conditions remain unchanged and in full force and effect.
Earth Science Tech, Inc. reported a change in its independent auditor. On February 17, 2026, Stephano Slack LLC resigned as the company’s independent registered public accounting firm. Its prior audit reports for the year ended March 31, 2025 contained no adverse opinions, disclaimers, or qualifications.
The company states there were no disagreements or reportable events with Stephano Slack under SEC Regulation S-K during the referenced periods. Also on February 17, 2026, Earth Science Tech engaged Semple, Marchal & Cooper, LLP as its new independent PCAOB auditor for the fiscal year ending March 31, 2026 and issued a press release describing this engagement.
Earth Science Tech, Inc. reported a strong third fiscal quarter 2026 with revenue of $8.4 million, up 14.1% year-over-year, and gross margin expanding to 76.3% from 69.2%. Net income jumped to $910,000 from $206,000, while Adjusted EBITDA rose to $1.2 million from $0.3 million.
The Company highlighted improving balance sheet quality, with total assets of $8.1 million, working capital of $773,000, no bank debt, and 3.7 million shares repurchased and retired over nine months. Multiple operating units are generating positive cash flow, and Peaks, its telemedicine platform, surpassed $2.0 million in revenue in under a year.
Management and the Board announced governance and cost initiatives expected to deliver approximately $1.4 million in annualized savings, supporting an increase in net income from about $3.3 million in fiscal 2025 to a projected $4.7 million in fiscal 2026. Actions include voiding CEO and COO employment contracts, waiving variable pay in the interim, reducing Board meeting fees to $2,000, planning a non-binding say-on-pay vote, evaluating retirement of Series B preferred stock, and targeting divestiture of non-core assets.
Earth Science Tech, Inc. filed a current report to disclose that it has issued a press release about an industry classification update. On January 6, 2026, the company announced a directive industry classification update to Standard Industrial Classification (SIC) code 2834, which is used for pharmaceutical-related entities. The disclosure notes that the company has formally identified as a pharmaceutical entity since 2022. The press release describing this classification update is included as an exhibit to the report.
Earth Science Tech, Inc. reported that on January 5, 2026 it issued a press release announcing its engagement with Hayden IR. The company furnished this update as an "Other Event" and attached the full press release as Exhibit 99.1 to provide additional detail about the new engagement.
Earth Science Tech, Inc. (ETST) filed an 8-K announcing it issued a press release sharing results for the period ended September 30, 2025. The disclosure is furnished under Item 7.01 (Regulation FD) and is not deemed “filed” for purposes of Section 18, nor incorporated by reference unless expressly stated. Exhibit 99.1 contains the press release, and Exhibit 104 provides the cover page Inline XBRL data. The report was signed by Giorgio R. Saumat, CEO and Chairman.
Earth Science Tech (ETST) amended its Articles of Incorporation to reduce its authorized common stock, lowering the limit from 350,000,000 to 300,000,000 shares. The change was approved by majority shareholder written consent and a corporate resolution on August 19, 2025, and the State of Florida stamped and uploaded the amendment on October 10, 2025.